Conference call and webcast with Masimo CEO and CFO to begin after markets
close at 2:00 p.m. PT (5:00 p.m. ET)
IRVINE, Calif., April 18 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and
Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced it
will release first quarter financial results for the period ended
March 29, 2008 after the market closes on Tuesday, April 29, 2008.
A conference call to review the results will begin at 2:00 p.m. PT
(5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and Chief
Executive Officer, and Mark P. de Raad, Executive Vice President & Chief
Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the Company's corporate web site at
http://www.masimo.com. The dial-in numbers are (866) 831-6247 for domestic
callers and (617) 213-8856 for international callers. The reservation number
for both dial-in numbers is 82345350. After the live webcast, the call will
remain available on Masimo's web site through May 29, 2008. In addition, a
telephonic replay of the call will be available until May 13, 2008. The replay
dial-in numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for
international callers. Please use reservation code 71776300.
About Masimo
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse
oximetry, known as Masimo SET, which virtually eliminated false alarms and
increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most reliable SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral perfusion. In
2005, Masimo introduced Masimo Rainbow SET, a breakthrough noninvasive blood
constituent monitoring platform that can measure many blood constituents that
previously required invasive procedures. Rainbow SET continuously and
noninvasively measures total hemoglobin (SpHbTM) and oxygen content (SpOCTM)
(both pending regulatory clearances), carboxyhemoglobin (SpCO(R)),
methemoglobin (SpMet(R)), and PVITM, in addition to oxyhemoglobin (SpO2),
pulse rate (PR), and perfusion index (PI), allowing early detection and
treatment of potentially life-threatening conditions. Founded in 1989, Masimo
has the mission of "Improving Patient Outcomes and Reducing Cost of Care by
Taking Noninvasive Monitoring to New Sites and Applications." Additional
information about Masimo and its products may be found at
http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse CO-Oximeter
are trademarks or registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation
CONTACT: investors, Mark P. de Raad, Executive Vice President and Chief
Financial Officer, +1-949-297-7080, mderaad@masimo.com, or Dana Banks,
+1-949-297-7348, dbanks@masimo.com, both of Masimo Corporation
Web site: http://www.masimo.com